K

Kenvue

Organization

Heard in 27 episodes across 4 shows since Sep 2025

Kenvue Inc. is an American consumer health company that was formerly the Consumer Healthcare division of Johnson & Johnson. It owns a portfolio of well-known global brands, including Aveeno, Band-Aid, Neutrogena, Listerine, and Tylenol.

Episodes

27
across 4 shows

First heard

Sep 2025

Expert statements

5
5 positive

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Dec 20250
Jan 20264
Feb 20260
Mar 20261
Apr 20262
May 20261
Jun 20263
Jul 20264
Aug 20260
Sep 20261
Oct 20263
Nov 20262

Email alert

Email me when Kenvue comes up on a podcast

One email a week at most, with the new episodes that mention Kenvue. Free, no account needed, unsubscribe in one click.

What experts have said about Kenvue

5 statements · 5 positive

  1. Bryn says Kimberly-Clark’s Kenvue combination will produce $2 billion in synergies.

    “They just combine with Kenview. So what happens is as that Kenview merger happens, they shove out $2 billion in synergies.”

    Listen at 1:02:53

    Open the episode · The AI Bubble Already Popped with Jenny Harrington and Bryn Talkington
  2. Jim CramerPositiveNov 20, 2025· Mad Money w/ Jim Cramer

    Kenvue long-term shareholders should be fine despite lawsuits.

    “I think the answer is no. I think you'll be fine.”

    Listen at 37:17

    Open the episode · Mad Money w/ Jim Cramer 11/19/25
  3. Mike SchubertPositiveNov 4, 2025· Mad Money w/ Jim Cramer

    The Kimberly-Clark–Kenvue merger will create a leading global health and wellness company.

    “This is really about two great, iconic American companies joining forces to what to create what we think is the preeminent. global health and wellness leader.”

    Listen at 11:02

    Open the episode · Mad Money w/ Jim Cramer 11/3/25

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

27 episodes featuring Kenvue, newest first